Literature DB >> 2717617

Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

A Sette1, S Buus, E Appella, J A Smith, R Chesnut, C Miles, S M Colon, H M Grey.   

Abstract

We have previously experimentally analyzed the structural requirements for interaction between peptide antigens and mouse major histocompatibility complex (MHC) molecules of the d haplotype. We describe here two procedures devised to predict specifically the capacity of peptide molecules to interact with these MHC class II molecules (IAd and IEd). The accuracy of these procedures has been tested on a large panel of synthetic peptides of eukaryotic, prokaryotic, and viral origin, and also on a set of overlapping peptides encompassing the entire staphylococcal nuclease molecule. For both sets of peptides, IAd and IEd binding was successfully predicted in approximately 75% of the cases. This suggests that definition of such sequence "motifs" could be of general use in predicting potentially immunogenic peptide regions within proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717617      PMCID: PMC287118          DOI: 10.1073/pnas.86.9.3296

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  T-cell antigenic sites tend to be amphipathic structures.

Authors:  C DeLisi; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Immunological self, nonself discrimination.

Authors:  J G Guillet; M Z Lai; T J Briner; S Buus; A Sette; H M Grey; J A Smith; M L Gefter
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

3.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors:  H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

4.  Structural analysis of peptides capable of binding to more than one Ia antigen.

Authors:  A Sette; S Buus; S Colon; C Miles; H M Grey
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

Review 5.  The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site.

Authors:  G Gammon; N Shastri; J Cogswell; S Wilbur; S Sadegh-Nasseri; U Krzych; A Miller; E Sercarz
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

6.  Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells.

Authors:  A Sette; S Buus; S Colon; J A Smith; C Miles; H M Grey
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

7.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

8.  I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif.

Authors:  A Sette; S Buus; S Colon; C Miles; H M Grey
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

9.  Interaction of an immunodominant epitope with Ia molecules in T-cell activation.

Authors:  L Adorini; A Sette; S Buus; H M Grey; M Darsley; P V Lehmann; G Doria; Z A Nagy; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

  10 in total
  89 in total

1.  Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.

Authors:  O Schueler-Furman; Y Altuvia; A Sette; H Margalit
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

2.  Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.

Authors:  Morten Nielsen; Claus Lundegaard; Peder Worning; Sanne Lise Lauemøller; Kasper Lamberth; Søren Buus; Søren Brunak; Ole Lund
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

3.  Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition.

Authors:  Anish Suri; James J Walters; Osami Kanagawa; Michael L Gross; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

4.  A novel predictive technique for the MHC class II peptide-binding interaction.

Authors:  Matthew N Davies; Clare E Sansom; Claude Beazley; David S Moss
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

5.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.

Authors:  Pedro A Reche; John-Paul Glutting; Hong Zhang; Ellis L Reinherz
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

Review 6.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 7.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

8.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003

9.  Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.

Authors:  A C Griffin; W Zhao; K W Wegmann; W F Hickley
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

10.  Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.

Authors:  M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.